December 2021 • PharmaTimes Magazine • 4-5


Contents


Features

Meet the best of the best in 2021


The need for diversity and inclusion


A look at the digital landscape and rare cancer patients


The rise of the empowered patient


Improving client communications


Luca’s journey through diagnosis and treatment


Analysis

Finding a more holistic, outcomes-led strategy


The key developments this year


What’s next for the pharmaceutical industry?


Maintaining the industry’s pivotal role


The promise of gene therapy


SmartPeople

12.
Smart People: Laetitia Decroix Guilloux
PharmaTimes talks to Laetitia Decroix Guilloux, Vice President Oncology, EMEA and Commercial Strategy Lead at Janssen about the role of precision medicine in non-small cell lung cancer


13.
Thought Leadership
COUCH CEO Ash Rishi addresses implicit bias in clinical trials


29.
Thought Leadership
Advanz Pharma’s CEO Graeme Duncan reflects on 2021